Gastrointestinal Cancer News

VIENNA — A new algorithm accurately predicted hepatocellular carcinoma among a cohort of patients with cirrhosis, according to a study presented at the 2015 International Liver Congress.

The FDA today announced the approval of ramucirumab for use in combination with FOLFIRI chemotherapy for the treatment of certain patients with metastatic colorectal cancer.

VIENNA — As non-alcoholic fatty liver disease reaches ‘epidemic’ status, its relation to hepatocellular carcinoma is also on the rise with a higher rate of mortality among those patients with fatty liver-related carcinoma, according to a study presented at the 2015 International Liver Congress.

PHILADELPHIA — The diabetes drug metformin was not associated with improved survival outcomes for patients with pancreatic cancer, according to retrospective study data presented at the American Association for Cancer Research Annual Meeting.

Volatile organic compound marker detection-based nanoarray technology differentiated gastric cancer and precancerous lesions with high accuracy, according to results from a recent clinical trial.

VIENNA — A number of patients with alcohol-related cirrhosis developed hepatocellular carcinoma and other complications over time, regardless of alcohol and tobacco consumption, according to data presented at the 2015 International Liver Congress.

VIENNA — Clinicians stopped a trial of novel tyrosine kinase inhibitor TSU-68 in hepatocellular carcinoma after the drug failed to best placebo in overall survival in patients with hepatocellular carcinoma, according to findings presented at the 2015 International Liver Congress.

VIENNA — Exome sequencing of liver tumors was found to be effective in determining relationships between environmental exposures and mutation signatures, which may assist in determining therapy for patients with hepatocellular carcinoma in the future, according to data presented at a press conference at the 2015 International Liver Congress.

The prognosis of colorectal cancer is worse in patients aged 35 years or younger compared with older patients, according to data presented at the Society of American Gastrointestinal and Endoscopic Surgeons 2015 Annual Meeting.

PHILADELPHIA — Regular, long-term aspirin use was associated with a reduced risk for cancer, especially gastrointestinal cancers, according to prospective study results presented at the American Association for Cancer Research Annual Meeting.